These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7652556)

  • 21. The human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5.
    Stern MJ; Marengere LE; Daly RJ; Lowenstein EJ; Kokel M; Batzer A; Olivier P; Pawson T; Schlessinger J
    Mol Biol Cell; 1993 Nov; 4(11):1175-88. PubMed ID: 8305738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic structure and 5' regulatory regions of the let-23 gene in the nematode C. elegans.
    Sakai T; Koga M; Ohshima Y
    J Mol Biol; 1996 Mar; 256(3):548-55. PubMed ID: 8604137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. sli-1, a negative regulator of let-23-mediated signaling in C. elegans.
    Jongeward GD; Clandinin TR; Sternberg PW
    Genetics; 1995 Apr; 139(4):1553-66. PubMed ID: 7789760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.
    Thien CB; Walker F; Langdon WY
    Mol Cell; 2001 Feb; 7(2):355-65. PubMed ID: 11239464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
    Levkowitz G; Waterman H; Ettenberg SA; Katz M; Tsygankov AY; Alroy I; Lavi S; Iwai K; Reiss Y; Ciechanover A; Lipkowitz S; Yarden Y
    Mol Cell; 1999 Dec; 4(6):1029-40. PubMed ID: 10635327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LET-23 receptor localization by the cell junction protein LIN-7 during C. elegans vulval induction.
    Simske JS; Kaech SM; Harp SA; Kim SK
    Cell; 1996 Apr; 85(2):195-204. PubMed ID: 8612272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and characterization of a novel cbl-family gene, cbl-c.
    Kim M; Tezuka T; Suziki Y; Sugano S; Hirai M; Yamamoto T
    Gene; 1999 Oct; 239(1):145-54. PubMed ID: 10571044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
    Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J
    J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
    Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
    Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARK-1 inhibits EGFR signaling in C. elegans.
    Hopper NA; Lee J; Sternberg PW
    Mol Cell; 2000 Jul; 6(1):65-75. PubMed ID: 10949028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C. elegans gene lin-36 acts cell autonomously in the lin-35 Rb pathway.
    Thomas JH; Horvitz HR
    Development; 1999 Aug; 126(15):3449-59. PubMed ID: 10393123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A point mutation in the extracellular domain activates LET-23, the Caenorhabditis elegans epidermal growth factor receptor homolog.
    Katz WS; Lesa GM; Yannoukakos D; Clandinin TR; Schlessinger J; Sternberg PW
    Mol Cell Biol; 1996 Feb; 16(2):529-37. PubMed ID: 8552080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of ETS genes in C. elegans.
    Hart AH; Reventar R; Bernstein A
    Oncogene; 2000 Dec; 19(55):6400-8. PubMed ID: 11175356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. sur-2, a novel gene, functions late in the let-60 ras-mediated signaling pathway during Caenorhabditis elegans vulval induction.
    Singh N; Han M
    Genes Dev; 1995 Sep; 9(18):2251-65. PubMed ID: 7557379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cbl oncogene: a novel substrate of protein tyrosine kinases.
    Langdon WY
    Aust N Z J Med; 1995 Dec; 25(6):859-64. PubMed ID: 8770364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cbl-3: a new mammalian cbl family protein.
    Keane MM; Ettenberg SA; Nau MM; Banerjee P; Cuello M; Penninger J; Lipkowitz S
    Oncogene; 1999 Jun; 18(22):3365-75. PubMed ID: 10362357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The c-Cbl oncoprotein.
    Lupher ML; Andoniou CE; Bonita D; Miyake S; Band H
    Int J Biochem Cell Biol; 1998 Apr; 30(4):439-44. PubMed ID: 9675877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.